CD274 and breast cancer: As revealed by related studies on advanced-stage BC, it is suggested to focus on investigating the application of checkpoint inhibitors in early treatment and conducting enrichment therapy for patients having a larger number of immunogenic tumors (e.g., PD-L1 expression and stromal T cell infiltration occurred before treatment).